The expression and action of decay-accelerating factor (CD55) in human malignancies and cancer therapy.

Antje Roetger , Jan-Henrik Mikesch , Horst Buerger , Ronald Simon
Analytical Cellular Pathology 28 223 -232

34
2006
Early Placenta Insulin-like Growth Factor (pro-EPIL) Is Overexpressed and Secreted by c-erbB-2-positive Cells with High Invasion Potential

Jens Packeisen , Antje Roetger , Katrin Schier , Horst Buerger
Cancer Research 62 ( 4) 1020 -1024

21
2002
Migrating and circulating breast carcinoma cells are within active phases of the cell cycle.

Kurt S. Zänker , Burkhard Brandt , Britta S. Kubens , Julia C. Feldner
Anticancer Research 22 899 -903

2002
Breast stem cells spontaneously fuse with breast cancer cells: Impacts on cancer stem cell formation?

Kurt Zanker , Bernd Niggemann , Sarah Schwitalla , Sonke Meyer-Staeckling
Cancer Research 68 5007 -5007

5
2008
The Long-Term Prognostic Significance of Circulating Tumor Cells in Ovarian Cancer-A Study of the OVCAD Consortium.

Robert Zeillinger , Linn Woelber , Eva Obermayr , Sven Mahner
Cancers 13 ( 11) 2613

2021
Pro-Inflammatory wnt5a and Anti-Inflammatory sFRP5 Are Differentially Regulated by Nutritional Factors in Obese Human Subjects

Dominik M. Schulte , Nike Müller , Katrin Neumann , Frank Oberhäuser
PLOS ONE 7 ( 2)

83
2012
Cytokeratin alteration in oral leukoplakia and oral squamous cell carcinoma

Thomas Fillies , Mirco Jogschies , Johannes Kleinheinz , Burkhard Brandt
Oncology Reports 18 ( 3) 639 -643

42
2007
Cell cycle regulating proteins p21 and p27 in prognosis of oral squamous cell carcinomas.

Thomas Fillies , Mike Woltering , Burkhard Brandt , Jean-Paul Van Diest
Oncology Reports 17 ( 2) 355 -359

47
2007
Exploring Prostate Cancer Genome Reveals Simultaneous Losses of PTEN, FAS and PAPSS2 in Patients with PSA Recurrence after Radical Prostatectomy

Chinyere Ibeawuchi , Hartmut Schmidt , Reinhard Voss , Ulf Titze
International Journal of Molecular Sciences 16 ( 2) 3856 -3869

9
2015
Decay-accelerating factor (CD55): a versatile acting molecule in human malignancies.

Jan-Henrik Mikesch , Horst Buerger , Ronald Simon , Burkhard Brandt
Biochimica et Biophysica Acta 1766 ( 1) 42 -52

37
2006
Selective expression of a splice variant of decay-accelerating factor in c-erbB-2-positive mammary carcinoma cells showing increased transendothelial invasiveness.

Burkhard Brandt , Jan-Hendrik Mikesch , Ronald Simon , Antje Rötger
Biochemical and Biophysical Research Communications 329 ( 1) 318 -323

5
2005
Do Modifications of Nonequimolar Assays for Total Prostate-specific Antigen Improve Detection of Prostate Cancer?

Axel Semjonow , Frank Oberpenning , Christoph Weining , Manuel Schön
Clinical Chemistry 47 ( 8) 1472 -1475

27
2001
HIF1-alpha overexpression indicates a good prognosis in early stage squamous cell carcinomas of the oral floor

Thomas Fillies , Richard Werkmeister , Paul J van Diest , Burkhard Brandt
BMC Cancer 5 ( 1) 84 -84

104
2005
Cytokeratin 8/18 expression indicates a poor prognosis in squamous cell carcinomas of the oral cavity

Thomas Fillies , Richard Werkmeister , Jens Packeisen , Burkhard Brandt
BMC Cancer 6 ( 1) 10 -10

161
2006
217
2020
Detection and clinical relevance of early disseminated breast cancer cells depend on their cytokeratin expression pattern

Katharina E. Effenberger , Elin Borgen , Christine zu Eulenburg , Kai Bartkowiak
Breast Cancer Research and Treatment 125 ( 3) 729 -738

29
2011
Distinct functional roles of Akt isoforms for proliferation, survival, migration and EGF-mediated signalling in lung cancer derived disseminated tumor cells

Nicole Grabinski , Kai Bartkowiak , Katharina Grupp , Burkhard Brandt
Cellular Signalling 23 ( 12) 1952 -1960

93
2011
AKT3 regulates ErbB2, ErbB3 and estrogen receptor α expression and contributes to endocrine therapy resistance of ErbB2(+) breast tumor cells from Balb-neuT mice.

Nicole Grabinski , Katharina Möllmann , Karin Milde-Langosch , Volkmar Müller
Cellular Signalling 26 ( 5) 1021 -1029

23
2014